spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  clofarabine 

 HSMN NewsFeed - 15 Oct 2012
Promedior Appoints Elizabeth Trehu, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2010
Infinity Augments Executive Leadership Team, Appointing New Chief Medical Officer and New Vice President, Product Development and Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Oct 2010
Genzyme Announces Results of Phase 3 Trial of Clolar in Adult AML
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Dec 2008
FDA Approves Genzyme's Mozobil
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Mar 2008
Genzyme Withdraws Bioenvision's European Filing of Evoltra(R) in Elderly AML Patients
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Oct 2007
Bioenvision Shareholders Approve Acquisition by Genzyme Corporation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Oct 2007
Delaware Court Approves Bioenvision, Genzyme Joint Petition
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Oct 2007
Bioenvision and Genzyme File Petition in Delaware Court
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Sep 2007
Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding Share
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Aug 2007
Bioenvision Provides Evoltra(R) (clofarabine) Regulatory Update
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 7 Feb 2007
Bioenvision Files with EMeA for Label Extension of Evoltra(R)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 5 Feb 2007
Bioenvision Appoints General Manager in Japan
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Dec 2006
Bioenvision Provides Update on Evoltra(R) European Regulatory Activities
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 11 Dec 2006
New Evoltra(R) Data Shows Impressive Response and Survival Rates
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Nov 2006
Genzyme Begins Phase 2 Pivotal Study of Clolar(R) in Adult Acute Myelogenous Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Oct 2006
Bioenvision Names Vice President of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2006
Latest Data Confirm Benefits of Evoltra(R) in Children with Relapsed/Refractory Acute Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Sep 2006
Bioenvision to Expand into Japan and Southeast Asia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Sep 2006
Bioenvision to Formally Launch Evoltra(R) Throughout Europe
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Sep 2006
Genzyme Begins Phase 3 Pivotal Study of Clolar(R) in Adult Acute Myelogenous Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 May 2006
Bioenvision and Mayne Pharma Announce Marketing and Distribution Agreement for Evoltra(R)
Biopharmaceuticals Oncology Distribution
Return to NewsFeed  

 Additional items found! 56

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 56 additional stories matching:
clofarabine
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.